Fact sheet - Articles - Page 37

Fact Sheet

How to Ask DSM-5 Focused Questions for Alcohol Use Disorder

January 1, 2025

Daniel Carlat, MD, Michael Weaver, MD, FASAM, and Talia Puzantian, PharmD, BCPP

Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Alcohol use disorder (AUD), as defined in the DSM-5, includes 11 criteria.

Fact Sheet

Clinical Institute Withdrawal Assessment for Alcohol Scale, Revised

January 1, 2025

Daniel Carlat, MD, Michael Weaver, MD, FASAM, and Talia Puzantian, PharmD, BCPP

Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

The Clinical Institute Withdrawal Assessment for Alcohol Scale, Revised (CIWA-Ar) is the most widely used alcohol withdrawal symptom scale.

Fact Sheet

Blood Alcohol Level Fact Sheet

January 1, 2025

Daniel Carlat, MD, Michael Weaver, MD, FASAM, and Talia Puzantian, PharmD, BCPP

Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Blood alcohol level (BAL, sometimes called BAC for blood alcohol concentration) is often used in emergency rooms to give insight into the severity of a patient’s alcohol use and to help guide predictions about when they will be sober enough for a psychiatric evaluation and when they may start to experience withdrawal.

Fact Sheet

Alcohol Withdrawal Time Course and Symptoms

January 1, 2025

Daniel Carlat, MD, Michael Weaver, MD, FASAM, and Talia Puzantian, PharmD, BCPP

Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Alcohol withdrawal symptom onset: Usually within six to eight hours of last drink, though in some very heavy drinkers, withdrawal may not begin until 24 hours after last drink.

Fact Sheet

Alcohol Use Disorder: Tips for the Initial Assessment

January 1, 2025

Daniel Carlat, MD, Michael Weaver, MD, FASAM, and Talia Puzantian, PharmD, BCPP

Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

This fact sheet suggests a typical flow of questions during a conversational initial assessment of a patient’s alcohol use.

Fact Sheet

Alcohol Use Disorder: Initial Evaluation Template

January 1, 2025

Daniel Carlat, MD, Michael Weaver, MD, FASAM, and Talia Puzantian, PharmD, BCPP

Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

This template can be downloaded and adapted for your charting, or you can use it as a guide to remind you of important topics to cover during the initial interview.

Fact Sheet

Alcohol Use Disorder: Initial Evaluation Template

January 1, 2025

Daniel Carlat, MD, Michael Weaver, MD, FASAM, and Talia Puzantian, PharmD, BCPP

Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

This template can be downloaded and adapted for your charting, or you can use it as a guide to remind you of important topics to cover during the initial interview.

Fact Sheet

Al-Anon/Alateen Fact Sheet

January 1, 2025

Daniel Carlat, MD, Michael Weaver, MD, FASAM, and Talia Puzantian, PharmD, BCPP

Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

When family members need support from others who are also struggling with a loved one’s substance use issues, referring them to Al-Alon or Alateen is a great option.

Fact Sheet

Transcranial Magnetic Stimulation (TMS) Fact Sheet on the Inpatient Unit

January 1, 2025

Victoria Hendrick, MD and Daniel Carlat, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Transcranial Magnetic Stimulation (TMS) is a non-invasive neuromodulation technique primarily used to treat major depressive disorder.

Fact Sheet

Orthostatic Hypotension Fact Sheet

January 1, 2025

Victoria Hendrick, MD and Daniel Carlat, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

A rare but potentially life-threatening drug reaction presenting with muscle rigidity (“lead pipe”), hyperthermia, and altered mental status.

Articles Tagged with ''Fact Sheet''

How to Ask DSM-5 Focused Questions for Alcohol Use Disorder

Clinical Institute Withdrawal Assessment for Alcohol Scale, Revised

Blood Alcohol Level Fact Sheet

Alcohol Withdrawal Time Course and Symptoms

Alcohol Use Disorder: Tips for the Initial Assessment

Alcohol Use Disorder: Initial Evaluation Template

Alcohol Use Disorder: Initial Evaluation Template

Al-Anon/Alateen Fact Sheet

Transcranial Magnetic Stimulation (TMS) Fact Sheet on the Inpatient Unit

Orthostatic Hypotension Fact Sheet

Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

Treating BPD Series, Episode 2: Transference-Focused Psychotherapy—From Splitting to Coherence with Frank Yeomans, MD, PhD

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

About

Shop Online

Newsletters

Contact

Follow Us